{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:58:31Z","timestamp":1769716711874,"version":"3.49.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Cleveland Clinic Research Program Committee","award":["RPC 4314"],"award-info":[{"award-number":["RPC 4314"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We sought to validate previously proposed immunohistochemistry (IHC) markers that classify meningiomas into 4 molecular groups (MG) with superior predictive ability of progression compared to World Health Organization (WHO) grade. IHC for target proteins S100B, SCGN, ACADL, and MCM2 corresponding to molecular groups 1-4, respectively, was performed on 85 surgically resected primary meningiomas across WHO grades 1-3. Additional IHC for FOXM1 was included as a potential predictor of aggressiveness. All slides were digitally analyzed for percent of cells staining positive. The primary outcome measure was time to progression. In addition, 9% cell positivity was identified as the optimal cutoff although 31% of tumors could not be classified and only 53% (n\u2009=\u200945) were positive for a single, unique molecular group. Within these uniquely categorized tumors, there was no significant difference in time to progression between MG1-2 versus MG3-4 (P\u2009=\u2009.7). In a separate analysis, high staining of MCM2 (MG4) was associated with shorter time to progression (P\u2009=\u2009.02). Although the previously proposed IHC targets to identify molecular groups were not meaningfully reproducible in our analysis, MCM2 staining alone correlated with shorter time to progression across all grades and may be a simple, cost-effective IHC marker to identify clinically aggressive meningiomas.<\/jats:p>","DOI":"10.1093\/jnen\/nlaf120","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:37:55Z","timestamp":1760445475000},"page":"179-184","source":"Crossref","is-referenced-by-count":0,"title":["Validation of an immunohistochemistry-based molecular group stratification of intracranial meningiomas"],"prefix":"10.1093","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-3209","authenticated-orcid":false,"given":"Roger","family":"Murayi","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH,","place":["United States"]},{"name":"Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Abtah","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Ejikeme","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Prayson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranay","family":"Soni","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH,","place":["United States"]},{"name":"Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo F","family":"Recinos","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH,","place":["United States"]},{"name":"Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun R","family":"Kshettry","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH,","place":["United States"]},{"name":"Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Neurological Institute, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2026012903013524100_nlaf120-B1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026012903013524100_nlaf120-B2","first-page":"643","article-title":"Interobserver variability in mitotic count for meningioma grading: how can we reduce it?","volume":"30","author":"Saygin","year":"2020","journal-title":"Turk Neurosurg"},{"key":"2026012903013524100_nlaf120-B3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/neuonc\/nov247","article-title":"Pathology concordance levels for meningioma classification and grading in NRG oncology RTOG trial 0539","volume":"18","author":"Rogers","year":"2016","journal-title":"Neuro Oncol"},{"key":"2026012903013524100_nlaf120-B4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2026012903013524100_nlaf120-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2026012903013524100_nlaf120-B6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026012903013524100_nlaf120-B7","doi-asserted-by":"crossref","first-page":"21715","DOI":"10.1073\/pnas.1912858116","article-title":"Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors","volume":"116","author":"Patel","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012903013524100_nlaf120-B8","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026012903013524100_nlaf120-B9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro Oncol"},{"key":"2026012903013524100_nlaf120-B10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"2026012903013524100_nlaf120-B11","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","article-title":"Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation","volume":"22","author":"Vasudevan","year":"2018","journal-title":"Cell Rep"},{"key":"2026012903013524100_nlaf120-B12","doi-asserted-by":"crossref","first-page":"101711","DOI":"10.1016\/j.bas.2022.101711","article-title":"Meningioma classification by immunohistochemistry: a replicability study","volume":"3","author":"N\u00e4slund","year":"2023","journal-title":"Brain Spine"},{"key":"2026012903013524100_nlaf120-B13","author":"Fox","year":"2022"},{"key":"2026012903013524100_nlaf120-B14","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1074\/jbc.M809471200","article-title":"The minichromosome maintenance proteins 2-7 (MCM2-7) are necessary for RNA polymerase II (pol II)-mediated transcription","volume":"284","author":"Snyder","year":"2009","journal-title":"J Biol Chem"},{"key":"2026012903013524100_nlaf120-B15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/modpathol.2016.231","article-title":"MCM2: an alternative to Ki-67 for measuring breast cancer cell proliferation","volume":"30","author":"Yousef","year":"2017","journal-title":"Mod Pathol"},{"key":"2026012903013524100_nlaf120-B16","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1200\/JCO.2003.04.121","article-title":"Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer","volume":"21","author":"Gonzalez","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026012903013524100_nlaf120-B17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jnen\/nlad082","article-title":"Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype","volume":"82","author":"Shelbourn","year":"2023","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026012903013524100_nlaf120-B18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00428-023-03537-2","article-title":"Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk","volume":"483","author":"Barresi","year":"2023","journal-title":"Virchows Arch"},{"key":"2026012903013524100_nlaf120-B19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-019-02008-w","article-title":"Mutational patterns and regulatory networks in epigenetic subgroups of meningioma","volume":"138","author":"Paramasivam","year":"2019","journal-title":"Acta Neuropathol"},{"key":"2026012903013524100_nlaf120-B20","doi-asserted-by":"crossref","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/85\/2\/179\/64713877\/nlaf120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/85\/2\/179\/64713877\/nlaf120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:01:45Z","timestamp":1769673705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/85\/2\/179\/8287204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlaf120","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,15]]}}}